Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it will hold a conference ...

LUND, SE / ACCESS Newswire / April 20, 2026 / Alligator Bioscience (STO:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today announced that ...

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced a strategic partnership with Turbine, a leading virtual biology company, to advance ...

South Korea's Penetrium Bioscience unveiled a novel approach to cancer treatment that targets the environments surrounding ...

New data highlight predictive patient-derived models, resistance insights, and end-to-end translational workflows to improve translational oncology confidence ...

On December 2, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations, of which NH Life Sciences is a member, released a new report, “The U.S. Bioscience ...

In a recent interview, Robert Fried, CEO of Niagen Bioscience, delves into the science of aging and the pivotal role of a molecule known as NAD (nicotinamide adenine dinucleotide). He explains how NAD ...

A new Bend-based bioscience lab could become operational as early as December of this year, with manufacturing and analytical capabilities coming online in mid-2023. Earlier this month, the ...

Niagen Bioscience, Inc. (NASDAQ:NAGE) is among the 12 Cheap Penny Stocks to Invest In Now. On March 31, Niagen Bioscience, Inc. (NASDAQ:NAGE) announced a strategic partnership with OneSpaWorld to ...

Twist Bioscience shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Margaret R. McLean delivered this address to the Keck Graduate Institute Convocation in September 2010. She is associate director of the Markkula Center for Applied Ethics and Director of Bioethics.